000 | 01917 a2200517 4500 | ||
---|---|---|---|
005 | 20250518041630.0 | ||
264 | 0 | _c20201022 | |
008 | 202010s 0 0 eng d | ||
022 | _a2045-2322 | ||
024 | 7 |
_a10.1038/s41598-019-44050-4 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKalakh, Samah | |
245 | 0 | 0 |
_aEnhanced remyelination during late pregnancy: involvement of the GABAergic system. _h[electronic resource] |
260 |
_bScientific reports _c05 2019 |
||
300 |
_a7728 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aPregnancy |
650 | 0 | 4 | _aRats |
650 | 0 | 4 |
_a3-Oxo-5-alpha-Steroid 4-Dehydrogenase _xphysiology |
650 | 0 | 4 |
_a5-alpha Reductase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aBicuculline _xpharmacology |
650 | 0 | 4 |
_aCorpus Callosum _xpathology |
650 | 0 | 4 |
_aDemyelinating Diseases _xchemically induced |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aFinasteride _xpharmacology |
650 | 0 | 4 |
_aGABA Antagonists _xpharmacology |
650 | 0 | 4 |
_aLysophosphatidylcholines _xtoxicity |
650 | 0 | 4 |
_aMicroglia _xphysiology |
650 | 0 | 4 | _aMultiple Sclerosis |
650 | 0 | 4 |
_aMyelin Proteins _xbiosynthesis |
650 | 0 | 4 |
_aMyelin Sheath _xpathology |
650 | 0 | 4 |
_aNerve Tissue Proteins _xdrug effects |
650 | 0 | 4 |
_aOligodendrocyte Precursor Cells _xpathology |
650 | 0 | 4 |
_aOligodendroglia _xpathology |
650 | 0 | 4 |
_aPregnancy Complications _xphysiopathology |
650 | 0 | 4 |
_aPregnanolone _xpharmacology |
650 | 0 | 4 |
_aPuerperal Disorders _xphysiopathology |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReceptors, GABA-A _xdrug effects |
650 | 0 | 4 | _aRemyelination |
700 | 1 | _aMouihate, Abdeslam | |
773 | 0 |
_tScientific reports _gvol. 9 _gno. 1 _gp. 7728 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41598-019-44050-4 _zAvailable from publisher's website |
999 |
_c29719393 _d29719393 |